SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.
State Street SPDR S&P Biotech ETF (XBI) trades at $151.64, down 0.75% on the day, as of Oct 23, 2026 00:44 UTC.
State Street SPDR S&P Biotech ETF has a market capitalisation of $7.93B, calculated from the live XBI share price and shares outstanding.
State Street SPDR S&P Biotech ETF generated revenue of $0.00 over the trailing twelve months.
XBI has traded between $106.30 and $169.89 over the past 52 weeks, and the last price is 10.7% below that high.
Wall Street analysts rate XBI Hold.
State Street SPDR S&P Biotech ETF is classified under the Financial Services sector and the Asset Management industry, and is domiciled in US.
QFI Terminal shows XBI with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open XBI in Terminal See plans